Institute of Translational Medicine, The First Hospital, Jilin University, Changchun, China.
Cell Immunol. 2013 Jul-Aug;284(1-2):98-103. doi: 10.1016/j.cellimm.2013.07.012. Epub 2013 Aug 2.
Plasmacytoid dendritic cells (pDCs) are reported to be defective in HCV-infected patients, the mechanisms of which remain poorly understood. We isolated liver derived mononuclear cells (LMNCs) and pDCs from normal liver tissues of benign tumor dissections and liver transplant donors. Isolated pDCs and LMNCs were cultured with precoated HCV envelop protein E2 (HCV-E2) or anti-CD81 mAb in the presence of CpG-ODN. Our results show that cross-linking of CD81 by either HCV-E2 or anti-CD81 mAb inhibits IFN-α secretion in CpG-induced pDCs; down-regulates HLA-DR, CD80 and CD86 expression in pDCs; and suppresses CpG-ODN induced proliferation and survival of pDCs. The blockade of CD81 by soluble anti-CD81 antibody restores pDCs response to CpG-ODN. These results suggest that HCV E2 protein interacts with CD81 to inhibit pDC maturation, activation, and IFN-α production, and may thereby contribute to the impaired innate anti-viral immune response in HCV infection.
浆细胞样树突状细胞(pDCs)在 HCV 感染患者中被报道存在缺陷,但其机制仍知之甚少。我们从良性肿瘤切除术和肝移植供体的正常肝组织中分离出肝脏来源的单核细胞(LMNCs)和 pDCs。将分离出的 pDCs 和 LMNCs 与预包被的 HCV 包膜蛋白 E2(HCV-E2)或抗 CD81 mAb 在 CpG-ODN 的存在下进行培养。我们的结果表明,无论是 HCV-E2 还是抗 CD81 mAb 交联 CD81 均可抑制 CpG 诱导的 pDC 中 IFN-α 的分泌;下调 pDC 中 HLA-DR、CD80 和 CD86 的表达;并抑制 CpG-ODN 诱导的 pDC 增殖和存活。可溶性抗 CD81 抗体阻断 CD81 可恢复 pDC 对 CpG-ODN 的反应。这些结果表明,HCV E2 蛋白与 CD81 相互作用可抑制 pDC 的成熟、激活和 IFN-α 的产生,从而可能导致 HCV 感染中先天抗病毒免疫反应受损。